Skip to main content

NeuroStim TMS Expands Company Leadership, Hires Dano Jukanovich as Executive Vice President and Chief Financial Officer

Leading transcranial magnetic stimulation (TMS) provider grows their leadership to guide the company's continued growth and expansion throughout the northwest United States, increasing patient access to cutting-edge treatments.

(PRUnderground) October 16th, 2023

Founded in 2018 with a single location, NeuroStim TMS has quickly grown to become one of the leading providers of TMS therapy with ten locations across the Pacific Northwest. Specializing exclusively in TMS, the NeuroStim team of doctors and staff includes leading experts in the field. Together, they are committed to pioneering the latest treatments for individuals with mental health diagnoses, including major depressive disorder (MDD), obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), anxiety, and many others. As NeuroStim continues to expand, opening new treatment centers throughout the West, their leadership team is also growing to include a new EVP and CFO, Dano Jukanovich.

After graduating from West Point at the top of his class, Jukanovich served in the military as a Senior Intelligence Officer and Army Ranger. He then went to on to earn an MBA from Wharton and an MA from Johns Hopkins. His long leadership career includes having served as Director of Finance for AT&T Wireless and Philips Healthcare. He is also Co-founder of a leading social impact private equity firm in East Africa. And his most recent role was as Chief Operating Officer for ARCpoint Labs, where he helped grow this healthcare franchise system to over $100M in revenue and 130 locations while spearheading its public listing on the Toronto Venture Exchange.

NeuroStim TMS successfully treats individuals for whom many traditional treatments have not worked, yielding a higher-than-average success rate in treating patients’ symptoms with TMS. With FDA approval and coverage from many insurance companies, demand for TMS therapy continues to grow, fueling growth for industry leaders like NeuroStim.

“We are proud to have Dano Junkanovich join the NeuroStim team,” stated Walt Guidice, CEO of NeuroStim TMS. “NeuroStim’s exponential growth is gratifying. However, seizing these opportunities to open new clinics in new areas and bring TMS to more people requires a strong team at every level of the organization. Dano’s diverse background in business and finance makes him an invaluable asset to our management team as we navigate the challenges of rapid expansion.”

Since opening its doors five years ago, NeuroStim TMS has provided over 130,000 treatments. Their team of ten providers administers over 220 standard and accelerated TMS treatments daily. Assisted by 30 TMS technicians and five specialists, NeuroStim helps restore patients’ hope and improve their quality of life through non-invasive, outpatient treatments. Their high quality of clinical care, ethics, and respect make NeuroStim a sought-after provider of TMS therapy, with patients often traveling many miles to receive treatments at NeuroStim clinics.

To learn more about NeuroStim’s unique approach to treating mental health conditions with TMS therapy or schedule a consultation at one of their treatment centers, call (888) 963-9467 or visit www.NeuroStimTMS.com.

About NeuroStim TMS Treatment Centers

NeuroStim TMS Center is a leading expert in TMS treatment with patient outcomes higher than national averages. Their mission is to restore hope and improve people’s lives by pioneering the latest cutting-edge treatments for people suffering from clinical depression and similar debilitating disorders.

The post NeuroStim TMS Expands Company Leadership, Hires Dano Jukanovich as Executive Vice President and Chief Financial Officer first appeared on

Press Contact

Name: NeuroStim TMS Treatment Centers
Phone: 1-855-736-6285
Email: Contact Us

Original Press Release.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.